With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias||Children’s Hospital of Philadelphia / Alix Seif, MD||Epidemiology Grants||2016||Pennsylvania|
|Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma||Children’s Hospital Los Angeles / Sunhye Lee, PhD||Young Investigator Grants||2016||California|
|Targeted Combination Therapy to Sensitize High-Risk Acute Lymphoblastic Leukemia to Methotrexate via Restoration of Ikaros Tumor Suppression||The Pennsylvania State University / Sinisa Dovat, MD/PhD & Chunhua Song, MD/PhD||Innovation Grants||2016||Pennsylvania|
|Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy||Boston Children’s Hospital / George Q. Daley, MD/PhD||Innovation Grants||2016||Massachusetts|
|Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression||University of Colorado Denver / Melanie Vincent, PhD||Young Investigator Grants||2016||Colorado|
|Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma||University of Pennsylvania / Nicole Anderson, PhD||Young Investigator Grants||2016||Pennsylvania|
|Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia||University of Rochester / Craig Mullen, MD/PhD||Innovation Grants||2016||New York|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|Targeting PLK1 as a Common Mechanism in Ph-like ALL||University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD||Reach Grants||2016||Texas|
|Targeting the Function of Ezrin in Rhabdomyosarcoma||The Cleveland Clinic Foundation / Neetu Gupta, PhD & Peter Anderson, MD||Innovation Grants||2016||Ohio|